Searching for a cure for deadly brain tumors
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
March 23, 2022
The University of Cincinnati's Michael Hegener, PharmD, was featured in a HuffPost article about different health issues pharmacists can help patients with beyond filling prescriptions.
March 21, 2022
The University of Cincinnati's Jordan Kharofa, MD, joined 55KRC's Simply Medicine radio show and podcast to discuss Colorectal Cancer Awareness Month.
March 17, 2022
MSN featured University of Cincinnati research led by Alberto Espay and Luca Marsili that is expanding genetic testing of rare movement disorders for Chilean patients.
March 17, 2022
WVXU featured the University of Cincinnati's Dr. Tahir Latif in a news story about how immunocompromised people are navigating life with most mask guidelines being lifted.
March 15, 2022
55KRC featured University of Cincinnati researcher Jiajie Diao on the Simply Medicine program to discuss advances in a new probe and imaging technique to get a better view of human cells.
March 14, 2022
55KRC featured the University of Cincinnati's Dr. Timothy Phoenix on the Simply Medicine program, discussing his research into treatments for diffuse midline glioma, a deadly pediatric brain tumor.
March 10, 2022
The University of Cincinnati's Daniel Arendt, PharmD, examines discriminatory policies throughout the history of U.S. drug policy and how they have led to the stigmatization of patients suffering from painful conditions as "drug seekers."
March 9, 2022
Inside Precision Medicine featured recent University of Cincinnati research led by Dr. Trisha Wise-Draper showing adding immunotherapy to standard of care treatments for head and neck cancer increased survival rates for intermediate risk patients.
March 8, 2022
University of Cincinnati researchers Kim Seroogy, Teresa Reyes and James Herman were featured on 55KRC's Simply Medicine program to discuss their research into the role of stress in Parkinson's disease.